Trial Parameters
Condition Alzheimer Disease
Sponsor Central Hospital, Nancy, France
Study Type OBSERVATIONAL
Phase N/A
Enrollment 50,000
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2013-07-12
Completion 2050-12-31
All Conditions
Brief Summary
Today, the Alzheimer's disease (AD) diagnosis is founded not only on clinical criteria but also on complementary examinations to confirm a physiopathological process of AD. In complex cases, lumbar punction could be necessary in order to measure Aβ peptides and Total and phosphorylated Tau but new biomarkers could be useful. The main objective of this project is to conserve these cerebrospinal fluids, collected in usual practice in order to validate new biomarkers for diagnosis, prognosis or therapeutic following of Alzheimer's disease and other dementia.
Eligibility Criteria
Inclusion Criteria: * Lumbar punction collected in usual practice in the context of dementia diagnosis Exclusion Criteria: * Absence of consent
Related Trials
NCT06661564
Identification of Diagnosis Biomarkers in the Tears of Alzheimer's Disease Patients: The COG-EYE Pil
View Trial →
NCT06808984
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitati
View Trial →
NCT06116084
Randomized Controlled Study Evaluating the Efficacy of Hypnosis in Nuclear Medicine
View Trial →